Dr. P. Tajik MD PhD

Main activities
Development and Evaluation of Biomarkers for Predicting Treatment Effects in Clinical Trials: Method
Focus of research

1. Developing methods for identification and evaluation of markers to guide treatment decisions

2. Identification and evaluation of markers for guiding treatments for ovarian cancer patients


Key publications
  • Tajik P, van der Ham DP, Zafarmand MH, Hof MHP, Morris J, Franssen MTM, de Groot CJM, Duvekot JJ, Oudijk MA, Willekes C, Bloemenkamp KWM, Porath M, Woiski M, Akerboom BM, Sikkema JM, Nij Bijvank B, Mulder ALM, Bossuyt PM, Mol BWJ, Using vaginal Group B Streptococcus colonisation in women with preterm premature rupture of membranes to guide the decision for immediate delivery: a secondary analysis of the PPROMEXIL trials. BJOG-INT J OBSTET GY 2014;121 (10):1263-72; discussion 1273 [PubMed]
  • Tajik P, Zwinderman AH, Mol BW, Bossuyt PM, Trial designs for personalizing cancer care: a systematic review and classification. CLIN CANCER RES 2013;19 (17):4578-4588 [PubMed]
  • Tajik P, Bossuyt PM, Genomic markers to tailor treatments: waiting or initiating?. HUM GENET 2011;130 (1):15-18 [PubMed]
  • Tajik P. Markers to guide treatment decisions: Methods and applications in obstetrics and gynecology. S.l.: s.n.; 2015. 196p. ISBN 978-94-6259-575-0 [UvA Dissertations Online] Proefschrift Universiteit van Amsterdam. (Promotor(s): Bossuyt PMM, Mol BWJ; copromotor(s): )
  • van Meurs HS, Tajik P, Hof MHP, Vergote I, Kenter GG, Mol BWJ, Buist MR, Bossuyt PM, Which patients benefit most from primary surgery or neoadjuvant chemotherapy in stage IIIC or IV ovarian cancer? An exploratory analysis of the European Organisation for Research and Treatment of Cancer 55971 randomised trial. EUR J CANCER 2013;49 (15):3191-3201 [PubMed]
All Publications
Research programmes

Prof. dr. G.G. Kenter MD PhD (gynaecologic Oncology)

Prof. dr. P.M.M. Bossuyt (BIomarker and Test Evaluation program (BITE))

Current research funding
  • Biopartner, ALW-NWO